Danilova, O. V., Dumont, L. J., Levy, N. B., Lansigan, F., Kinlaw, W. B., Danilov, A. V., & Kaur, P. (2013). FASN and CD36 predict survival in rituximab-treated diffuse large B-cell lymphoma. J Hematop.
Citación estilo ChicagoDanilova, Olga V., Larry J. Dumont, Norman B. Levy, Frederick Lansigan, William B. Kinlaw, Alexey V. Danilov, y Prabhjot Kaur. "FASN and CD36 Predict Survival in Rituximab-treated Diffuse Large B-cell Lymphoma." J Hematop 2013.
Cita MLADanilova, Olga V., et al. "FASN and CD36 Predict Survival in Rituximab-treated Diffuse Large B-cell Lymphoma." J Hematop 2013.
Precaución: Estas citas no son 100% exactas.